12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The accurate measurement of β-amyloid (Aβ) change using amyloid PET imaging is important for Alzheimer disease research and clinical trials but poses several unique challenges. In particular, reference region measurement instability may lead to spurious changes in cortical regions of interest. To optimize our ability to measure (18)F-florbetapir longitudinal change, we evaluated several candidate regions of interest and their influence on cortical florbetapir change over a 2-y period in participants from the Alzheimer Disease Neuroimaging Initiative (ADNI).

          Related collections

          Author and article information

          Journal
          J. Nucl. Med.
          Journal of nuclear medicine : official publication, Society of Nuclear Medicine
          1535-5667
          0161-5505
          Apr 2015
          : 56
          : 4
          Affiliations
          [1 ] Helen Wills Neuroscience Institute, University of California, Berkeley, California Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California slandau@berkeley.edu.
          [2 ] Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California.
          [3 ] Radiology Department, University of Michigan, Ann Arbor, Michigan.
          [4 ] Avid Radiopharmaceuticals, Inc., Philadelphia, Pennsylvania; and.
          [5 ] Banner Alzheimer's Institute, Phoenix, Arizona.
          [6 ] Helen Wills Neuroscience Institute, University of California, Berkeley, California Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California.
          Article
          jnumed.114.148981
          10.2967/jnumed.114.148981
          25745095
          e5b098da-1377-4070-9207-4d5c41790738
          © 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
          History

          Alzheimer’s disease,PET imaging,amyloid
          Alzheimer’s disease, PET imaging, amyloid

          Comments

          Comment on this article